These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25081910)

  • 1. Oil-based emulsion vaccine adjuvants.
    Schijns VEJC; Strioga M; Ascarateil S
    Curr Protoc Immunol; 2014 Aug; 106():2.18.1-2.18.7. PubMed ID: 25081910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsaturated Squalene Content in Emulsion Vaccine Adjuvants Plays a Crucial Role in ROS-Mediated Antigen Uptake and Cellular Immunity.
    Huang CH; Huang CY; Huang MH
    Mol Pharm; 2018 Feb; 15(2):420-429. PubMed ID: 29237267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
    Aucouturier J; Dupuis L; Deville S; Ascarateil S; Ganne V
    Expert Rev Vaccines; 2002 Jun; 1(1):111-8. PubMed ID: 12908518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate--a revisit of the role of the hydrophile-lipophile balance (HLB) value.
    Yang YW; Wei AC; Shen SS
    Vaccine; 2005 Apr; 23(20):2665-75. PubMed ID: 15780450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of size on particulate vaccine adjuvants.
    Shah RR; O'Hagan DT; Amiji MM; Brito LA
    Nanomedicine (Lond); 2014 Dec; 9(17):2671-81. PubMed ID: 25529570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraction and characterization of vaccine antigens from water-in-oil adjuvant formulations.
    Miles AP; Saul A
    Methods Mol Biol; 2005; 308():293-300. PubMed ID: 16082043
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvants in veterinary vaccines: modes of action and adverse effects.
    Spickler AR; Roth JA
    J Vet Intern Med; 2003; 17(3):273-81. PubMed ID: 12774966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy.
    Huang CH; Huang CY; Cheng CP; Dai SH; Chen HW; Leng CH; Chong P; Liu SJ; Huang MH
    Sci Rep; 2016 Nov; 6():36732. PubMed ID: 27827451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emulsion Adjuvants for Use in Veterinary Vaccines.
    Madera R; Burakova Y; Shi J
    Methods Mol Biol; 2022; 2412():247-253. PubMed ID: 34918248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relations of water-in-oil vaccine formulations and induced antigen-specific antibody responses.
    Jansen T; Hofmans MP; Theelen MJ; Schijns VE
    Vaccine; 2005 Jan; 23(8):1053-60. PubMed ID: 15620479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of droplet size on performance.
    Shah RR; Dodd S; Schaefer M; Ugozzoli M; Singh M; Otten GR; Amiji MM; O'Hagan DT; Brito LA
    J Pharm Sci; 2015 Apr; 104(4):1352-61. PubMed ID: 25600347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4
    Schmidt ST; Neustrup MA; Harloff-Helleberg S; Korsholm KS; Rades T; Andersen P; Christensen D; Foged C
    Pharm Res; 2017 Aug; 34(8):1716-1727. PubMed ID: 28516400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication.
    Maynard SK; Marshall JD; MacGill RS; Yu L; Cann JA; Cheng LI; McCarthy MP; Cayatte C; Robbins SH
    BMC Cancer; 2019 Jun; 19(1):540. PubMed ID: 31170937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug Products.
    Iyer V; Cayatte C; Marshall JD; Sun J; Schneider-Ohrum K; Maynard SK; Rajani GM; Bennett AS; Remmele RL; Bishop SM; McCarthy MP; Muralidhara BK
    J Pharm Sci; 2017 Jun; 106(6):1490-1498. PubMed ID: 28259764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations.
    Miles AP; McClellan HA; Rausch KM; Zhu D; Whitmore MD; Singh S; Martin LB; Wu Y; Giersing BK; Stowers AW; Long CA; Saul A
    Vaccine; 2005 Mar; 23(19):2530-9. PubMed ID: 15752840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen delivery for cross priming via the emulsion vaccine adjuvants.
    Shen SS; Yang YW
    Vaccine; 2012 Feb; 30(9):1560-71. PubMed ID: 22230588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvants for human vaccines--current status, problems and future prospects.
    Gupta RK; Siber GR
    Vaccine; 1995 Oct; 13(14):1263-76. PubMed ID: 8585280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines.
    Galliher-Beckley A; Pappan LK; Madera R; Burakova Y; Waters A; Nickles M; Li X; Nietfeld J; Schlup JR; Zhong Q; McVey S; Dritz SS; Shi J
    Vaccine; 2015 Jun; 33(25):2903-8. PubMed ID: 25936722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of adjuvants in retroviral vaccines.
    Vogel FR
    Int J Immunopharmacol; 1995 Feb; 17(2):85-90. PubMed ID: 7657411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen.
    Richards RL; Rao M; Vancott TC; Matyas GR; Birx DL; Alving CR
    Immunol Cell Biol; 2004 Oct; 82(5):531-8. PubMed ID: 15479439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.